Genome-wide associations for benign prostatic hyperplasia reveal a genetic correlation with serum levels of PSA.

Thumbnail
Name:
Genome-wide associations ....pdf
Size:
824.5Kb
Format:
PDF
Download
Cast your vote
 
Your vote was cast
Thank you for your feedback
Authors
Gudmundsson, Julius
Sigurdsson, Jon K
Stefansdottir, Lilja
Agnarsson, Bjarni A
Isaksson, Helgi J
Stefansson, Olafur A
Gudjonsson, Sigurjon A
Gudbjartsson, Daniel F
Masson, Gisli
Frigge, Michael L
Stacey, Simon N
Sulem, Patrick
Halldorsson, Gisli H
Tragante, Vinicius
Holm, Hilma
Eyjolfsson, Gudmundur I
Sigurdardottir, Olof
Olafsson, Isleifur
Jonsson, Thorvaldur
Jonsson, Eirikur
Barkardottir, Rosa B
Hilmarsson, Rafn
Asselbergs, Folkert W
Geirsson, Gudmundur
Thorsteinsdottir, Unnur
Rafnar, Thorunn
Thorleifsson, Gudmar
Stefansson, Kari
Issue Date
2018-11-08

Metadata
Show full item record
Citation
Genome-wide associations for benign prostatic hyperplasia reveal a genetic correlation with serum levels of PSA. 2018, 9(1):4568 Nat Commun
Abstract
Benign prostatic hyperplasia and associated lower urinary tract symptoms (BPH/LUTS) are common conditions affecting the majority of elderly males. Here we report the results of a genome-wide association study of symptomatic BPH/LUTS in 20,621 patients and 280,541 controls of European ancestry, from Iceland and the UK. We discovered 23 genome-wide significant variants, located at 14 loci. There is little or no overlap between the BPH/LUTS variants and published prostate cancer risk variants. However, 15 of the variants reported here also associate with serum levels of prostate specific antigen (PSA) (at a Bonferroni corrected P < 0.0022). Furthermore, there is a strong genetic correlation, r
Description
To access publisher's full text version of this article, please click on the hyperlink in Additional Links field or click on the hyperlink at the top of the page marked Download
Additional Links
https://www.nature.com/articles/s41467-018-06920-9
Collections